Literature DB >> 23458239

Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen.

Poonam P Thankavel1, Arshid Mir1, Claudio Ramaciotti1.   

Abstract

BACKGROUND: Myocardial injury in previously healthy children is rare, with a wide range of aetiologies. It is increasingly being identified on the basis of elevated troponin levels during routine evaluation of cardiorespiratory symptoms. Establishing the aetiology remains challenging because of the lack of an accepted work-up algorithm. Our objective was to delineate the contribution of diagnostic modalities and troponin patterns towards the final diagnosis.
METHODS: A retrospective chart review of previously healthy patients admitted to the Pediatric Cardiology Service with myocardial injury was carried out. Data analysed included echocardiograms, electrocardiograms, cardiac catheterisations, magnetic resonance imaging, drug screen tests, troponin values, and final diagnosis.
RESULTS: A total of 32 patients were identified. The diagnoses were: myocarditis in 16 patients, vasospasm due to drug use in seven, myopericarditis in six, anomalous coronary artery origins in two, and Prinzmetal's angina in one patient. The electrocardiograms were abnormal in 27 of the 32 patients (84%), echocardiograms in 18 of the 32 patients (56%), cardiac magnetic resonance imaging in two of the four patients (50%), urine drug screen in five of the 25 patients (20%), and cardiac catheterisations in two of the 15 patients (13%).
CONCLUSIONS: Myocarditis is the most common aetiology of myocardial injury in children. Clinical history remains the basic screening tool; drug screens help identify coronary vasospasms secondary to drug use (22% of our cohort). Patients with anomalous coronaries had exertional symptoms. Initial troponin levels and progression were not diagnostic or prognostic. Catheterisation is of limited value and did not change management. Magnetic resonance imaging with gadolinium enhancement is probably the most useful test when initial evaluation is not diagnostic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458239     DOI: 10.1017/S1047951113000231

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  7 in total

1.  Outcomes of Myocarditis in Patients with Normal Left Ventricular Systolic Function on Admission.

Authors:  Spencer B Barfuss; Ryan Butts; Kenneth R Knecht; Adriana Prada-Ruiz; Ashwin K Lal
Journal:  Pediatr Cardiol       Date:  2019-06-08       Impact factor: 1.655

2.  What Raises Troponins in the Paediatric Population?

Authors:  Debbra Chong; Yan Ting Chua; Shu-Ling Chong; Gene Yong-Kwang Ong
Journal:  Pediatr Cardiol       Date:  2018-06-19       Impact factor: 1.655

3.  What is the Significance of Elevated Troponin I in Children and Adolescents? A Diagnostic Approach.

Authors:  Tamer Yoldaş; Utku Arman Örün
Journal:  Pediatr Cardiol       Date:  2019-09-04       Impact factor: 1.655

4.  Causes of Troponin Elevation and Associated Mortality in Young Patients.

Authors:  Candace Wu; Avinainder Singh; Bradley Collins; Amber Fatima; Arman Qamar; Ankur Gupta; Jon Hainer; Josh Klein; Petr Jarolim; Marcelo Di Carli; Khurram Nasir; Deepak L Bhatt; Ron Blankstein
Journal:  Am J Med       Date:  2018-01-10       Impact factor: 4.965

5.  Acute Myocarditis with Infarct-like Presentation in a Pediatric Population: Role of Cardiovascular Magnetic Resonance.

Authors:  Maria Martinez-Villar; Ferran Gran; Anna Sabaté-Rotés; Antonio Tello-Montoliu; Amparo Castellote; Marc Figueras-Coll; Queralt Ferrer; Ferran Roses-Noguer
Journal:  Pediatr Cardiol       Date:  2017-10-06       Impact factor: 1.655

Review 6.  Cardiac Biomarkers in Pediatrics: An Undervalued Resource.

Authors:  Mary Kathryn Bohn; Shannon Steele; Alexandra Hall; Jasmin Poonia; Benjamin Jung; Khosrow Adeli
Journal:  Clin Chem       Date:  2021-07-06       Impact factor: 12.167

7.  Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children.

Authors:  Audrey Dionne; John N Kheir; Lynn A Sleeper; Jesse J Esch; Roger E Breitbart
Journal:  J Am Heart Assoc       Date:  2020-02-13       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.